{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:06:19Z","timestamp":1754161579221,"version":"3.41.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1023\/a:1010649403659","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T22:31:49Z","timestamp":1040596309000},"page":"1684-1689","source":"Crossref","is-referenced-by-count":14,"title":["\u03b1-Interferon Improves Liver Fibrosis in Chronic Hepatitis C"],"prefix":"10.1007","volume":"46","author":[{"given":"F\u00e1tima","family":"Serejo","sequence":"first","affiliation":[]},{"given":"Adilia","family":"Costa","sequence":"additional","affiliation":[]},{"given":"A. Gouveia","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Ramalho","sequence":"additional","affiliation":[]},{"given":"Am\u00e9lia","family":"Batista","sequence":"additional","affiliation":[]},{"given":"Miguel Carneiro","family":"De Moura","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"issue":"Suppl1","key":"344381_CR1","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1002\/hep.510260703","volume":"26","author":"JH Hoofnagle","year":"1997","unstructured":"Hoofnagle JH: Hepatitis C. The clinical spectrum of disease. Hepatology26(Suppl 1):15S,1997","journal-title":"Hepatology"},{"issue":"Suppl11","key":"344381_CR2","doi-asserted-by":"crossref","first-page":"71S","DOI":"10.1002\/hep.510260713","volume":"26","author":"KL Lindsay","year":"1997","unstructured":"Lindsay KL: Therapy of hepatitis C: Overview.Hepatology26(Suppl 11):71S,1997","journal-title":"Hepatology"},{"key":"344381_CR3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0168-8278(96)80286-8","volume":"25","author":"M Ziol","year":"1996","unstructured":"Ziol M, Van Nhieu J, Roudot-Thoraval F, M\u00e9treau JM, Deugnier Y, Dhumeaux D, Zafrani ES:A histopathological study of the effects of 6 months versus 12 months interferon alfa 2b therapy in chronic hepatitis C.J Hepatol25:833\u2013841.1996","journal-title":"J Hepatol"},{"issue":"Suppl1","key":"344381_CR4","first-page":"89S","volume":"26","author":"HL William","year":"1997","unstructured":"William HL: Therapy of hepatitis C: interferon alfa 2a trials. Hepatology 26(Suppl 1):89S,1997","journal-title":"Hepatology"},{"issue":"Suppl12","key":"344381_CR5","first-page":"16S","volume":"13","author":"J Camps","year":"1991","unstructured":"Camps J, Granero G, Riezu BJ, Larrea E, Alava E, Civeira MP, Castilla A, Prieto J:Predictive factors of disease relapse after therapy with linfoblastoid interferon in chronic hepatitis C.J Hepatol13(Suppl 12):16S,1991","journal-title":"J Hepatol"},{"key":"344381_CR6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJM199104043241401","volume":"14","author":"A Castilla","year":"1991","unstructured":"Castilla A, Prieto J, Fausto N:Transforming growth factors b1 and a in cchronic liver disease. Effects of interferon alfa therapy.N Engl J Med14:933\u2013940,1991","journal-title":"N Engl J Med"},{"key":"344381_CR7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","volume":"349","author":"T Poynard","year":"1997","unstructured":"Poynard T, Bedossa P, Opolon P:Natural history of liver fibrosis progression in patients with chronic hepatitis.Lancet 349:825\u2013832,1997","journal-title":"Lancet"},{"issue":"Suppl1","key":"344381_CR8","first-page":"575","volume":"26","author":"R Perrillo","year":"1997","unstructured":"Perrillo R: The role of liver biopsy in hepatitis C.Hepatology 26(Suppl 1):575,1997","journal-title":"Hepatology"},{"key":"344381_CR9","doi-asserted-by":"crossref","unstructured":"Bissel MD:Connective tissue metabolism and hepatic fibrosis: An overview.Semin Liver Dis10:1\u201310,1990","DOI":"10.1055\/s-2008-1040491"},{"key":"344381_CR10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-2008-1040454","volume":"10","author":"LS Friedman","year":"1990","unstructured":"Friedman LS: Cellular sources of collagen and regulation of collagen production in liver.Semin Liver Dis10:20\u201329,1990","journal-title":"Semin Liver Dis"},{"key":"344381_CR11","unstructured":"Iredale JP:Matrix turnover in fibrogenesis.Hepatogastroenterology 43:56\u201371,1996"},{"key":"344381_CR12","first-page":"834","volume-title":"The Liver: Biology and Pathobiology","author":"M Rojkind","year":"1994","unstructured":"Rojkind M, Greenwel P: The extra-cellular matrix of the liver. In The Liver: Biology and Pathobiology,3rd ed.New York, Raven Press,1994, pp 834\u2013868","edition":"3rd ed."},{"key":"344381_CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0168-8278(85)80069-6","volume":"1","author":"EG Hann","year":"1985","unstructured":"Hann EG: Blood analysis for liver fibrosis.J Hepatol1:67\u201373, 1985","journal-title":"J Hepatol"},{"key":"344381_CR14","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/hep.1840190616","volume":"19","author":"J Iangun Li","year":"1994","unstructured":"Iangun Li J, Rosman AS, Leo MA, Nagai Y, Lieber CS: Tissue inhibitor of metalloproteinase is increased in the serum of pre-cirrhotic and cirrhotic patients and can serve as a marker of fibrosis.Hepatology 19:1418\u20131423,1994","journal-title":"Hepatology"},{"key":"344381_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0168-8278(95)80255-X","volume":"22","author":"J Gu\u00e9chot","year":"1995","unstructured":"Gu\u00e9chot J, Loria A, Surfact L, Giral P, Giboudeau J, Poupon R: Serum hyaluronic as a marker of liver fibrosis in chronic viral hepatitis C: Effect of a interferon therapy.J Hepatol 22:22\u201326,1995","journal-title":"J Hepatol"},{"key":"344381_CR16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-8278(00)80079-3","volume":"32","author":"KM Walsh","year":"2000","unstructured":"Walsh KM, Fletcher A, MacSween RNM, Morris AJ:Basement membrane peptides as markers of liver disease in chronic hepatitis C.J Hepatol32:325\u2013330,2000","journal-title":"J Hepatol"},{"key":"344381_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(99)80001-4","volume":"30","author":"I Tsushima","year":"1999","unstructured":"Tsushima I, Kawwata S, Tamura S, Ito N, Shirai Y: Reduced plasma transforming factor-b1 levels in patients with chronic hepatitis C after interferon atherapy: Association with regression of hepatic fibrosis.J Hepatol30:1\u20137,1999","journal-title":"J Hepatol"},{"key":"344381_CR18","doi-asserted-by":"crossref","unstructured":"Serejo F, Marinho R, Raimundo M, Ramalho F, Velosa J, Moura MC, Costa A, Batista A:The N-terminal propeptide of procollagen type III in chronic hepatitis c treated with a2 b interferon (IFN): Its correlation with histological activity. In Molecular and Cell Biology of Liver Fibrogenesis,Proceedings of the International Falk Symposium, Marburg,1992, pp 531\u2013537","DOI":"10.1016\/0168-8278(91)91655-Z"},{"issue":"5","key":"344381_CR19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/hep.1840040506","volume":"4","author":"K Weigang","year":"1984","unstructured":"Weigang K, Zaugg P, Frei A, Zimmerman A: Long term follow up of serum N-terminal Propeptide of collagen type III levels in patients with chronic liver disease.Hepatology4(5):835\u2013838,1984","journal-title":"Hepatology"},{"key":"344381_CR20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0168-8278(05)80018-2","volume":"18","author":"F Capra","year":"1993","unstructured":"Capra F, Casaril M, Gabrielli GB, Tognella P, Rizzi A, Dolci L, Colombari R, Mezzelani P, Corrocher R, De Sandre G: a interferon in the treatment of chronic viral hepatitis: Effects on fibrogenesis serum markers.J Hepatol18:112\u2013118,1993","journal-title":"J Hepatol"},{"key":"344381_CR21","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hep.1840200403","volume":"20","author":"M Yoshikasu","year":"1994","unstructured":"Yoshikasu M, Yugiro I, Masattiko K, Hironaka K: Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: Relationship to liver histology.Hepatology20:780\u2013787,1994","journal-title":"Hepatology"},{"key":"344381_CR22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI111480","volume":"74","author":"SA Jimenez","year":"1984","unstructured":"Jimenez SA, Freundlich B, Rosenbloon J: Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest74:1112\u20131116,1984","journal-title":"J Clin Invest"},{"key":"344381_CR23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hep.510300116","volume":"30","author":"GT Everson","year":"1999","unstructured":"Everson GT, Jansen DM, Craig JR, Leeuwen DV, Bain VG, Ehrinpreis MN, Donald A, Joh T, Witt K, Consensus Interferon Study Group: Efficacy of interferon treatment for patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics and non fibrotics.Hepatology 30:271\u2013276,1999","journal-title":"Hepatology"},{"key":"344381_CR24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","volume":"1","author":"RG Knodell","year":"1981","unstructured":"Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in assymptomatic chronic active hepatitis.Hepatology1:431\u2013435, 1981","journal-title":"Hepatology"},{"key":"344381_CR25","doi-asserted-by":"crossref","unstructured":"Scheuer PJ:Classification of chronic viral hepatitis. A need for reassessment.J Hepatol13:372\u2013374,1991","DOI":"10.1016\/0168-8278(91)90084-O"},{"key":"344381_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0676.1994.tb00070.x","volume":"14","author":"O Richard","year":"1994","unstructured":"Richard O, Glaumman H, Norkraus G, Wejstal R, Fryden A, Schwarkz R, Weiland O: Histological outcome in patients with chronic hepatitis C given a 60 week interferon alfa 2b treatment course.Liver14:169\u2013174,1994","journal-title":"Liver"},{"key":"344381_CR27","doi-asserted-by":"crossref","first-page":"243A","DOI":"10.1016\/0270-9139(93)92494-K","volume":"18","author":"P Marcellin","year":"1993","unstructured":"Marcellin P, Pouteau M, Duchatelle V, Degot PC, Degos F, Boyer N, Erlinger S, Benhamou PP: Post-treatment histologic outcome in patient with chronic hepatitis c treated with reconbinant alpha interferon.Hepatology18:243A,1993","journal-title":"Hepatology"},{"key":"344381_CR28","doi-asserted-by":"crossref","unstructured":"Friedman SL:Molecular regulation of hepatic fibrogenesis. J Hepatol29:836\u2013847,1998","DOI":"10.1016\/S0168-8278(98)80269-9"},{"key":"344381_CR29","first-page":"104","volume":"43","author":"CP Day","year":"1996","unstructured":"Day CP: Is necroinflamation a prerequisite for fibrogenesis? Hepatogastroenterology 43:104\u2013120,1996","journal-title":"Hepatogastroenterology"},{"key":"344381_CR30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/gut.37.2.274","volume":"37","author":"EJ Healey","year":"1995","unstructured":"Healey EJ, Chapman RWG, Flemming K: A Liver histology in hepatitis C infection: A comparison between patients with persistently normal or abnormal transaminases.Gut37:274\u2013278,1995","journal-title":"Gut"},{"key":"344381_CR31","first-page":"1250","volume":"90","author":"SE McCormick","year":"1996","unstructured":"McCormick SE, Goodman ZD, Donovitch MCL, Sjogren MH: Evaluation of liver histology, ALT elevation and HCV RNA titer in patients with chronic hepatitis C.Am J Gastroenterol 90:1250\u20131257,1996","journal-title":"Am J Gastroenterol"},{"key":"344381_CR32","first-page":"27","volume":"24","author":"I Kasunobu","year":"1996","unstructured":"Kasunobu I, Torukashiwagi, Akihito I, Yoshio T, Masafumi N, Takashi T, Shiniti O, Masafumi N, Masayoshi A:Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis C.Hepatology 24:27\u201331,1996","journal-title":"Hepatology"},{"key":"344381_CR33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/hep.1840220209","volume":"22","author":"S Takeaki","year":"1995","unstructured":"Takeaki S, Keiko O, Yukihiro K, Yasushihorie, Hironava K: Long term decrease in serum N-terminal propeptide of type III procollagen in patients treated with interferon alpha.Hepatology 22:426\u2013431,1995","journal-title":"Hepatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1010649403659.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1010649403659\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1010649403659.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T03:42:32Z","timestamp":1753760552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1010649403659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["344381"],"URL":"https:\/\/doi.org\/10.1023\/a:1010649403659","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}